|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | 330 N. Wabash Avenue, Chicago |
State | IL |
Zip Code | 60611 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III |
Date | 10/18/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013, all provisions
H.R. 2835, Restoring Access to Medication Act of 2013, all provisions
S. 1323, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013, all provisions
H.R. 3204, Drug Quality and Security Act, provisions relating to drug compounding
S. 959, Pharmaceutical Quality, Security, and Accountability Act, all provisions
H.R. 3089, Compounding Clarity Act of 2013, all provisions
H.R. 2094, School Access to Emergency Epinephrine Act, all provisions
H.R. 2073, Pulmonary Hypertension Research and Diagnosis Act of 2013, all provisions
Affordable Care Act - repeal of Section 9003 - HSA/FSA OTC drugs prescription requirement
Affordable Care Act Section 2607(a) - Provider Non-discrimination
Genetic Information Nondiscrimination Act
Personalized Medicine
Electronic Health Records - Meaningful Use Regulations
Health Information Technology
In-office Ancillary Services Exception
Prescription Drug Diversion and Abuse
Regulation of laboratory developed tests
Prescriber education and mandatory/voluntary CME training
Pay-for-delay
Physician Coding
Rogue Online/Internet Pharmacies
Telehealth/Telemedicine
Prescription Drug Compounding
Drug Shortages
ICD-10 Repeal
HIPAA Privacy/Security issues and accounting for disclosures
Physician Compare Redesign
Opioid Analgesics
Shared Savings/Accountable Care Organization program
Delivery Reform
Health Insurance Reform
Marketing of high stimulant/caffeine drinks to children
Sunshine Act
Supplemental Nutrition Assistance Program (SNAP)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Federal Trade Commission (FTC), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), Drug Enforcement Administration (DEA), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Matt |
Reid |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1310, Medicare Patient Empowerment Act of 2013, all provisions
S. 236, Medicare Patient Empowerment Act of 2013, all provisions
H.R. 351, Protecting Seniors' Access to Medicare Act of 2013, all provisions
S. 351, Protecting Seniors' Access to Medicare Act of 2013, all provisions
S. 1180, Medicare Data Access for Transparency and Accountability Act, all provisions
S. 452, Medicare Diabetes Prevention Act of 2013, all provisions
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 1179, Improving Access to Medicare Coverage Act of 2013, all provisions
S. 569, Improving Access to Medicare Coverage Act of 2013, all provisions
H.R. 2914, Promoting Integrity in Medicare Act of 2013, all provisions
The Medicare Payment Stability and Premium Security Act
Medicare program - Sustainable Growth Rate (SGR) Repeal
Medicare program - Physician Payment and Delivery Reform
Medicare program - Payment and Delivery Reform
Medicare program - New specialty models of care
Medicare program - Medicare Private Contracting
Medicare program - Independent Payment Advisory Board (IPAB) Repeal
Medicare program - Electronic Health Records - Meaningful Use Regulations
Medicare program - Graduate Medical Education
Medicare program - ICD-10 Repeal
Medicare program - Medicare Claims Data
Medicare program - In-office Ancillary Services Exception
Medicare program - Value-Based Modifier
Medicare program - Quality Resource Use Reports
Medicare program - Physician coding
Medicare program - MoPath codes
Medicare program - Hospital Out-patient Coding
Medicare program - Observation Care
Medicare program - Quality Improvement
Medicare program - Relative Value Scale Update Committee (RUC)
Medicare program - Program Integrity
Medicare program - Diabetes
Medicare program - Regulatory Reform
Medicare program - Recovery Audit Contractors (RACs)
Medicare program - Enrollment
Medicare program - HIPAA/ICD-10 and credit card fees
Medicare program - Care coordination coverage
Medicare program - Accountable Care Organizations exclusivity provisions
Medicare program - Shared Savings/Accountable Care organization program
Medicare program - Physician Quality Reporting System (PQRS)
Medicare program - Physician Compare
Medicare program - Recoupment of Claims for Incarcerated Beneficiaries
Medicare and Medicaid programs - Mental Health Reform
Medicaid program - Health insurance exchanges "grace period"
Medicaid program - Primary care payment increase
Medicaid program - Affordable Care Act implementation - Medicaid primary care incentive and pending claims
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Matt |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 214, Preserve Access to Affordable Generics Act, all provisions
S. 616, Conrad State 30 and Physician Access Act, all provisions
S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act, provisions relating to physician immigration reform
H.R. 2131, SKILLS Visa Act, provisions relating to physician immigration issues
DOJ-FTC Health Care Antitrust guidelines
Shared Savings/Accountable Care Organization program
Health Care Market Competition
Medical Licensing Boards and Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Justice - Dept of (DOJ), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1473, Standard of Care Protection Act of 2013, all provisions
H.R. 1733, Good Samaritan Health Professionals Act of 2013, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Tricare - Physician access issues
17. House(s) of Congress and Federal agencies Check if None
Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Mari |
Savickis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, provisions relating to GME funding
S. 577, Resident Physician Shortage Reduction Act of 2013, provisions relating to GME funding
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
BUD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |